Showing results (11-20 of 107) with videos related to
Sort By:
Pageof 11
Endocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Therapeutic targeting of B lymphocyte stimulator (BLyS) in the rheumatic diseasesWilliam StohlExpert Opinion on Biological Therapy|February 7, 2023
Belimumab for the treatment of pediatric patients with lupus nephritisWilliam Stohl, Alyssa KwokAutoimmunity|December 18, 2009
Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and futureNoam Jacob, William StohlClinical Immunology (Orlando, Fla.)|July 20, 2016
B cell-independent contribution of BAFF to murine autoimmune diseaseWilliam Stohl, Agnes BanfalviACR Open Rheumatology|September 7, 2023
Industry Payments to United States Rheumatologist-Authors of Publications in High-Impact Rheumatology JournalsWilliam Stohl, Krishan ParikhArthritis Research & Therapy|July 13, 2011
Cytokine disturbances in systemic lupus erythematosusNoam Jacob, William StohlJournal of Immunology (Baltimore, Md. : 1950)|March 28, 2020
Promotion of T Regulatory Cells in Mice by B Cells and BAFFWilliam Stohl, Ning YuExpert Opinion on Drug Safety|October 29, 2019
The safety of belimumab for the treatment of systemic lupus erythematosusLeanna M Wise, William StohlExpert Opinion on Therapeutic Targets|October 9, 2020
Systemic lupus erythematosus (SLE): emerging therapeutic targetsLauren M Mathias, William StohlClinical Immunology (Orlando, Fla.)|May 16, 2006
B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks?William Stohl, R John LooneyPageof 11